Brannan Stephen K. reported SER

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0001708599-25-000128

Machine-readable

Structured copy

Timestamps

Event (reported)

Nov 7, 2025

Published

Nov 10, 2025

Ingested by INSIDER

Nov 5, 04:33 UTC

Last re-read

Nov 5, 04:33 UTC

Extracted facts

Filer

Brannan Stephen K.

Role

Director

Transaction

Grant or awardAs filed: “A”

Asset

Serina Therapeutics, Inc. — Stock Option (right to buy)

Ticker

SER

Shares

10.0K

Price per share

$0

Execution date (reported)

Nov 7, 2025

Owned after transaction

10.0K shares

Days from execution to publication

3

What this establishes

Brannan Stephen K. filed this Form 4 reporting a grant or award of SER on Nov 7, 2025. It became public on Nov 10, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

Director

Brannan Stephen K.cik:0001777631

Issuer

Serina Therapeutics, Inc.cik:0001708599

Revision history · 0

No field has changed since this record was first ingested.